Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam prophylaxis after cranioplasty in patients with skull defect
ChiCTR-TRC-13003743Phase 4Completed
- Sponsor
- Fourth Medical Center of PLA General Hospital
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levetiracetam in postoperative seizure and epilepsy (2 arms), sponsored by Fourth Medical Center of PLA General Hospital. Primary endpoint: Seizure incidence rate. Started Feb 2014; status: completed.
02
Drugs
levetiracetam
03
Conditions
postoperative seizureepilepsy
Beyond the preview
Go deeper on ChiCTR-TRC-13003743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003743.